Cargando…
Antivascular endothelial growth factor‐A therapy: a novel personalized treatment approach for psoriasis
Chronic plaque psoriasis is an inflammatory skin disease in which genetic predisposition along with environmental factors lead to the development of the disease, which affects 2% of the UK’s population and is associated with extracutaneous morbidities and a reduced quality of life. A complex crossta...
Autores principales: | Luengas‐Martinez, Andrea, Paus, Ralf, Young, Helen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313866/ https://www.ncbi.nlm.nih.gov/pubmed/34878645 http://dx.doi.org/10.1111/bjd.20940 |
Ejemplares similares
-
Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
por: Luengas‐Martinez, Andrea, et al.
Publicado: (2023) -
Circadian rhythms in psoriasis and the potential of chronotherapy in psoriasis management
por: Luengas‐Martinez, Andrea, et al.
Publicado: (2022) -
Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019) -
Promising Novel Treatment against Keloids: Antivascular Endothelial Growth Factor Agents
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019) -
Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)